KPK2_PLAFK
ID KPK2_PLAFK Reviewed; 510 AA.
AC Q02595;
DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT 01-JUL-1993, sequence version 1.
DT 03-AUG-2022, entry version 93.
DE RecName: Full=Probable serine/threonine-protein kinase 2;
DE EC=2.7.11.1;
GN Name=PK2;
OS Plasmodium falciparum (isolate K1 / Thailand).
OC Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX NCBI_TaxID=5839;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=1378403; DOI=10.1111/j.1432-1033.1992.tb17051.x;
RA Zhao Y., Kappes B., Yang J., Franklin R.M.;
RT "Molecular cloning, stage-specific expression and cellular distribution of
RT a putative protein kinase from Plasmodium falciparum.";
RL Eur. J. Biochem. 207:305-313(1992).
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC EC=2.7.11.1;
CC -!- SUBCELLULAR LOCATION: Membrane.
CC -!- DEVELOPMENTAL STAGE: Is highly expressed during the young trophozoite
CC stage but gradually decreases in amount with further growth. No protein
CC can be detected during the ring stage, only small amount is expressed
CC during the schizont stage.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X63648; CAA45179.1; -; mRNA.
DR PIR; S23466; S23466.
DR AlphaFoldDB; Q02595; -.
DR SMR; Q02595; -.
DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR000719; Prot_kinase_dom.
DR InterPro; IPR017441; Protein_kinase_ATP_BS.
DR InterPro; IPR008271; Ser/Thr_kinase_AS.
DR Pfam; PF00069; Pkinase; 1.
DR SMART; SM00220; S_TKc; 1.
DR SUPFAM; SSF56112; SSF56112; 1.
DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE 2: Evidence at transcript level;
KW ATP-binding; Kinase; Membrane; Nucleotide-binding;
KW Serine/threonine-protein kinase; Transferase.
FT CHAIN 1..510
FT /note="Probable serine/threonine-protein kinase 2"
FT /id="PRO_0000086165"
FT DOMAIN 111..364
FT /note="Protein kinase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT REGION 408..428
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 230
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT ECO:0000255|PROSITE-ProRule:PRU10027"
FT BINDING 117..125
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 140
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
SQ SEQUENCE 510 AA; 59006 MW; 0605C3A73C76F4B9 CRC64;
MEKRYQQLFK GKRIDFPLAT GAASHVSLTY DEKKNPYLLC WTYIYQEKPE FTVPLKGCRI
INNITEIGPC IHIITSNEEY QFQCRSKEEF DEMSQFFNML GYPILGFKNV YVLNKKIGKG
SFSTAYIGTN ILYGNRVVVK EVDKSKVKES NVYTEIEVLR KVMHKYIIKL ISAYEQEGFV
YLVLEYLKGG ELFEYLNNNG PYTEQVAKKA MKRVLIALEA LHSNGVVHRD LKMENLMLEN
PNDPSSLKII DFGLASFLNS PSMNMRCGSP GYVAPEILKC ASYGTKVDIF SLGVILFNIL
CGYPPFRGNN VKEIFKKNMR CHISFNTKHW INKSESVKEI ILWMCCKNPD DRCTALQALG
HQWFLPKLTD MHMTANINEL KRNEAIVHKS NDQQDMCKKC KHFNNTQNDD IYNNNNNNNQ
LDPNKNHKNN YNDYKNYFDT MLKIDDKYSE NLIKDKTSMD SISLNKKDYD AYLVHSNEHD
TVVLHGKCQT TKNSSSLLSY KCSRRSPPQN